The Pancreatic Society of Great Britain & Ireland.


An alliance of professionals advancing the understanding and management of pancreatic conditions, for the benefit of patients.

(PERT) shortage

Position Statement: Pancreatic enzyme replacement therapy

Make a Donation to PSGBI

Help support our work

Grants and Bursaries

Funding for Member projects

Patients

Information for patients

Access the Journal

Free access for members

Our Mission:


The Pancreatic Society of Great Britain and Ireland will promote, encourage and support study and research into diseases of the pancreas and will actively promote professional discussions and dissemination of knowledge, for the benefit of patients and the public in the United Kingdom and Ireland. We will work to build professional relationships with other national societies throughout the world and support our members through shared learning from these relationships.

History: The first meeting of the Pancreatic Society of Great Britain and Ireland was held on 16 June 1975 at the Royal College of Surgeons of England.Sir Rodney Smith was elected as the first president of the Society and Mr Michael Knight as Secretary and Treasurer. Other officers elected at the meeting included Professor Henry Howat, Professor Patrick Collins, Mr Peter Bevan, Dr Martin Sarner and Mr John Trapnell.

The first presentation was given by Mr C W Imrie. At the first meeting there were sixty-eight participants. Since then the Society has held an annual meeting hosted by the President and regularly attended by over a hundred delegates.

The Pancreatic Society has close links with the British Society of Gastroenterology (BSG), the European Pancreatic Club (EPC) and the International Association of Pancreatology (IAP). The abstracts of the annual meeting of the Society are published in the journal “Pancreatology”.


 

 

News

There are no articles currently

Events

There are no upcoming events.

Pancreatology Journal, latest articles

Prescribing of pancreatic enzyme therapy for malabsorption in unresectable pancreatic cancer: cross-sectional survey across New Zealand and Australia

14 Oct 2024, 4 p.m.

Publication date: Available online 13 October 2024Source: PancreatologyAuthor(s): Amanda Landers, ...

Clinical significance and therapeutic implication of CD200 in pancreatic cancer

13 Oct 2024, 1 p.m.

Publication date: Available online 12 October 2024Source: PancreatologyAuthor(s): Shoichi Kinoshita, ...

A causal relationship between distinct immune features and acute or chronic pancreatitis: results from a mendelian randomization analysis

11 Oct 2024, 2 p.m.

Publication date: Available online 11 October 2024Source: PancreatologyAuthor(s): Rujuan Liu, ...

Alterations in the Gut Microbiota in Patients with Long-Term Follow-Up after Pancreaticoduodenectomy and Their Association with Postoperative Fatty Liver: A Pilot Study.

4 Oct 2024, 5 p.m.

Publication date: Available online 3 October 2024Source: PancreatologyAuthor(s): Yuichiro Uchida, ...

Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.

3 Oct 2024, 1 p.m.

Publication date: Available online 3 October 2024Source: PancreatologyAuthor(s): M. Reni, ...

Clinical impact of intraoperative pancreatic transection margin analysis and additional resection during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

2 Oct 2024, 5 p.m.

Publication date: Available online 1 October 2024Source: PancreatologyAuthor(s): Kakeru Tawada, ...

Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma

2 Oct 2024, 5 p.m.

Publication date: Available online 1 October 2024Source: PancreatologyAuthor(s): Yuki Hirose, ...

Rs1347093 regulates microRNA-216/-217 expression and is associated with pancreatic cancer risk

2 Oct 2024, 5 p.m.

Publication date: Available online 2 October 2024Source: PancreatologyAuthor(s): Hsin-Hung Huang, ...